Cited by 61

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Oxaliplatin immuno hybrid nanoparticles for active targeting: an approach for enhanced apoptotic activity and drug delivery to colorectal tumors

Tummala, Shashank, Gowthamarajan, K., Satish Kumar, M. N., Wadhwani, Ashish·2016·Drug Delivery

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/10717544.2015.1084400

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 32

  1. 10.2174/1567201043334605 · DOI
  2. 10.1016/j.biomaterials.2008.12.013 · DOI
  3. 10.1016/S0378-5173(96)04764-3 · DOI
  4. 10.1016/j.jconrel.2010.02.026 · DOI
  5. 10.1007/978-0-387-73898-7 · DOI
  6. Dhawale S, 2010, Int J Pharm Tech Res, 2, 1112
  7. 10.1016/S0009-2509(03)00234-3 · DOI
  8. 10.1016/j.ces.2007.08.006 · DOI
  9. 10.1016/j.ejphar.2009.06.066 · DOI
  10. Jain A, 2007, J Pharm Pharm Sci, 10, 86
  11. 10.1038/nrd2683 · DOI
  12. 10.1038/sj.cdd.4401187 · DOI
  13. 10.1038/nbt.1549 · DOI
  14. 10.1002/adfm.201401583 · DOI
  15. 10.1016/j.biomaterials.2009.09.036 · DOI
  16. 10.1016/j.carbpol.2012.12.032 · DOI
  17. 10.1016/j.semcancer.2005.06.005 · DOI
  18. 10.1200/JCO.2010.34.0760 · DOI
  19. Mohideen B, 2013, Int J Biol Pharm Res, 4, 533
  20. 10.1016/S0939-6411(00)00087-4 · DOI
  21. Radulovic S, 1991, Cancer Res, 51, 6006
  22. 10.1200/JCO.2003.11.045 · DOI
  23. 10.1038/nature03794 · DOI
  24. 10.1021/bm700753q · DOI
  25. Tummala S, 2014, Indo Am J Pharm Res, 4, 3579
  26. 10.1016/j.jsps.2014.11.010 · DOI
  27. 10.1021/am406012g · DOI
  28. 10.1056/NEJMp1101548 · DOI
  29. 10.1021/nn800275r · DOI
  30. Zhang L, 2015, Int J Nanomed, 10, 2101
  31. 10.1016/j.jconrel.2007.07.016 · DOI
  32. 10.1016/j.biomaterials.2014.12.028 · DOI

Cited by

Sorted by citations

See all 61

Metadata

Authors
Tummala, S., Gowthamarajan, K., Satish Kumar, M. N., & Wadhwani, A.
Venue
Drug Delivery
Published
2015-09-17
Volume
23
Issue
5
Pages
1773-1787
ISSN
  • 1071-7544
  • 1521-0464
Cited by
61
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review